Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:1276

Living Cell Technologies Limited (LCT) - Financial and Strategic SWOT Analysis Review

Living Cell Technologies Limited (LCT) - Financial and Strategic SWOT Analysis Review

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $125.00
Meta Description Living Cell Technologies Limited (LCT) is a biotechnology company that develops cell-based therapeutics for the treatment of neurological diseases, diabetes, stroke and hearing loss. Its product pipeline includes Diabecell and NTCell, for the treatment of
Publisher GlobalData
Date of Report Dec 3, 2013
Quick Overview
Summary

Living Cell Technologies Limited (LCT) is a biotechnology company that develops cell-based therapeutics for the treatment of neurological diseases, diabetes, stroke and hearing loss. Its product pipeline includes Diabecell and NTCell, for the treatment of Diabetes, Parkinson's disease, Huntington's disease, stroke and hearing loss, which are in various stages of development from preclinical to pivotal trials. The company's lead product, Diabecell is developed to normalize blood glucose levels in the patients suffering from type 1 diabetes.

Living Cell Technologies Limited Key Recent Developments

Dec 10, 2012: Living Cell Technologies Appoints Paul Tan As Chief Science And Medical Officer
Aug 29, 2012: Living Cell Technologies Reports Revenue Of AUD3.8m In Fiscal 2012
Feb 28, 2012: Living Cell Technologies Receives EU Patent For Tissue Engineering
Feb 28, 2012: Living Cell Technologies Reports Six Months Ended December 31, 2011 Results
Feb 01, 2012: Living Cell Technologies Receives US Patent For Tissue EngineeringGDPH61193FSA

This comprehensive SWOT profile of Living Cell Technologies Limited provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Living Cell Technologies Limited - Key Facts 5
Living Cell Technologies Limited - Key Employees 6
Living Cell Technologies Limited - Key Employee Biographies 7
Living Cell Technologies Limited - Major Products and Services 8
Living Cell Technologies Limited - Pharmaceutical Pipeline Products Data 9
Living Cell Technologies Limited, Pipeline Products by Therapy Area 9
Living Cell Technologies Limited, Pipeline Products by Development Phase 10
Living Cell Technologies Limited - History 12
Living Cell Technologies Limited - Company Statement 14
Living Cell Technologies Limited - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Section 2 – Company Analysis 17
Living Cell Technologies Limited - Business Description 17
Living Cell Technologies Limited - SWOT Analysis 18
SWOT Analysis - Overview 18
Living Cell Technologies Limited - Strengths 18
Strength - Intellectual Property Portfolio 18
Strength - Lead Product-Diabecell 18
Strength - Partnerships and Collaborations 18
Living Cell Technologies Limited - Weaknesses 18
Weakness - Limited Liquidity 18
Weakness - Geographic Concentration 19
Living Cell Technologies Limited - Opportunities 19
Opportunity - New Markets for Diabecell 19
Opportunity - Growing Market Potential: Diabetes 19
Opportunity - Emerging Markets 19
Living Cell Technologies Limited - Threats 19
Threat - Rapid Technological Changes 19
Threat - Product Liability Claims 20
Threat - Uncertain R&D Outcomes 20
Living Cell Technologies Limited - Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios - Capital Market Ratios 22
Financial Ratios - Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Living Cell Technologies Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 27
Living Cell Technologies Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 28
Living Cell Technologies Limited, Medical Equipment, Deals By Year, 2007 to YTD 2013 29
Living Cell Technologies Limited, Medical Equipment, Deals By Type, 2007 to YTD 2013 30
Living Cell Technologies Limited, Recent Deals Summary 31
Section 5 – Company’s Recent Developments 32
Living Cell Technologies Limited, Recent Developments 32
Dec 10, 2012: Living Cell Technologies Appoints Paul Tan As Chief Science And Medical Officer 32
Aug 29, 2012: Living Cell Technologies Reports Revenue Of AUD3.8m In Fiscal 2012 32
Feb 28, 2012: Living Cell Technologies Receives EU Patent For Tissue Engineering 33
Feb 28, 2012: Living Cell Technologies Reports Six Months Ended December 31, 2011 Results 33
Feb 01, 2012: Living Cell Technologies Receives US Patent For Tissue Engineering 33
Section 6 – Appendix 35
Methodology 35
Ratio Definitions 35
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Living Cell Technologies Limited, Key Facts 5
Living Cell Technologies Limited, Key Employees 6
Living Cell Technologies Limited, Key Employee Biographies 7
Living Cell Technologies Limited, Major Products and Services 8
Living Cell Technologies Limited, Number of Pipeline Products by Therapy Area 9
Living Cell Technologies Limited, Number of Pipeline Products by Development Stage 10
Living Cell Technologies Limited, Pipeline Products By Therapy Area and Development Phase 11
Living Cell Technologies Limited, History 12
Living Cell Technologies Limited, Subsidiaries 16
Living Cell Technologies Limited, Key Competitors 21
Living Cell Technologies Limited, Ratios based on current share price 22
Living Cell Technologies Limited, Annual Ratios 22
Living Cell Technologies Limited, Interim Ratios 25
Living Cell Technologies Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 27
Living Cell Technologies Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 28
Living Cell Technologies Limited, Medical Equipment, Deals By Year, 2007 to YTD 2013 29
Living Cell Technologies Limited, Medical Equipment, Deals By Type, 2007 to YTD 2013 30
Living Cell Technologies Limited, Recent Deals Summary 31
Currency Codes 35
Capital Market Ratios 35
Equity Ratios 36
Profitability Ratios 36
Cost Ratios 37
Liquidity Ratios 37
Leverage Ratios 38
Efficiency Ratios 38

List of Figures
Living Cell Technologies Limited, Pipeline Products by Therapy Area 9
Living Cell Technologies Limited, Pipeline Products by Development Phase 10
Living Cell Technologies Limited, Performance Chart (2008 - 2012) 24
Living Cell Technologies Limited, Ratio Charts 26
Living Cell Technologies Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 27
Living Cell Technologies Limited, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 28
Living Cell Technologies Limited, Medical Equipment, Deals By Year, 2007 to YTD 2013 29
Living Cell Technologies Limited, Medical Equipment, Deals by Type, 2007 to YTD 2013 30




...